UnitedHealth Group, Inc. (NYSE: UNH) Q4 2020 earnings call dated Jan. 20, 2021 Corporate Participants: David S. Wichmann -- Chief Executive Officer John Rex -- Office
UnitedHealth Group, Inc. (UNH) Q4 2020 Earnings Call Transcript
Categories
Health Care
Infographic: UnitedHealth Group (UNH) reports Q4 2020 earnings
UnitedHealth Group Incorporated (NYSE: UNH) reported fourth-quarter 2020 earnings results today. Revenues grew 7% to $65.5 billion year-over-year, helped by 21% growth
Covid vaccine won’t dent Ampio Pharma’s market: CEO Michael Macaluso
Since its foundation in 2008, Ampio Pharmaceuticals (NYSE: AMPE) has been focused on delivering a drug that treats inflammation caused by a
Johnson & Johnson’s (JNJ) COVID-19 vaccine would have an edge over others without this glitch
Johnson & Johnson (NYSE: JNJ) saw its shares climb 2% on Thursday after the company reported positive results from the early-stage trials
Rite Aid (RAD) looks to regain lost ground with new rebound strategy
Rite Aid Corporation (NYSE: RAD) is on a mission to put the house in order and achieve sustainable profitability, after prolonged volatility
Moderna (MRNA): Development programs, additional approvals provide optimism
Moderna Inc. (NASDAQ: MRNA) seems to be on a roll right now. The stock has skyrocketed over 500% in the past one
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice
Walgreens Boots Alliance, Inc. (WBA) Q1 2021 Earnings Call
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q1 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Gerald Gradwell — Senior Vice President of Special Projects
Trxade Group Inc. (NASDAQ: MEDS) Q4 2020 Research Summary
Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $45 million Trxade Group Inc (NASDAQ: MEDS) has been serving pharmacies and drug manufacturers for
Walgreens Boots Alliance, Inc. (WBA) Q1 2021 Earnings Call Transcript
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q1 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Gerald Gradwell -- Senior Vice President of Special
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive
Moderna’s (MRNA) stock gains on COVID-19 vaccine approval from the European Commission
Shares of Moderna Inc. (NASDAQ: MRNA) gained 6.3% in afternoon hours on Wednesday as the company received approval from the European Commission
COVID vaccine: Single-dose regimen can give Johnson & Johnson (JNJ) an edge
Johnson & Johnson (NYSE: JNJ) has adopted a slow and steady approach in its COVID vaccine research, which is one of the
Neogen Corp. (NEOG) Q2 2021 Earnings Call Transcript
Neogen Corp. (NASDAQ: NEOG) Q2 2021 earnings call dated Dec. 22, 2020 Corporate Participants: John Adent -- Chief Executive Officer and President Steve Quinlan -- Chief
Rite Aid Corporation (RAD) Q3 2021 Earnings Call
Rite Aid Corporation (NYSE: RAD) Q3 2021 earnings call dated Dec. 17, 2020. Corporate Participants: Trent Kruse — Senior Vice President, Investor Relations and
Rite Aid Corporation (RAD) Q3 2021 Earnings Call Transcript
Rite Aid Corporation (NYSE: RAD) Q3 2021 earnings call dated Dec. 17, 2020. Corporate Participants: Trent Kruse -- Senior Vice President, Investor Relations and
Infographic: Highlights of Rite Aid’s (RAD) Q3 2021 earnings report
Rite Aid Corporation (NYSE: RAD) reported a decline in third-quarter earnings, despite an increase in revenues, as margins were hurt by higher
Eli Lilly (LLY) is paving the way to a strong 2021
Shares of Eli Lilly & Co. (NYSE: LLY) were up over 2% on Wednesday. The stock has gained over 30% since the
Veru Inc. (VERU) Q4 2020 Earnings Call Transcript
Veru Inc. (NASDAQ: VERU) Q4 2020 earnings call dated Dec. 09, 2020. Corporate Participants: Samuel Fisch -- Director, Investor Relations Mitchell Steiner -- Chairman, President, and
One key stock you need to track ahead of COVID-19 vaccine approvals
It's been a spectacular year for many biotech and pharma investors who have made a killing out of the COVID-19 vaccine rally.
Is it time to book profits from Moderna?
Moderna (NASDAQ: MRNA) stock has soared a staggering 679% since the beginning of this year. If you did identify the potential of